Treatment Strategies for Acute Myocardial Infarction Complicated by Cardiogenic Shock in a Community Hospital

Stomel, Robert J.; Rasak, Mark; Bates, Eric R.

doi:10.1378/chest.105.4.997

Cited by 81 publications

(27 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…33 Nonrandomized studies report 33 to 45 percent mortality among patients selected for balloon counterpulsation and thrombolysis, often followed by late revascularization. 34,35 …”

Section: Discussionmentioning

confidence: 99%

Early Revascularization in Acute Myocardial Infarction Complicated by Cardiogenic Shock

et al. 1999

View full text Add to dashboard Cite

“…33 Nonrandomized studies report 33 to 45 percent mortality among patients selected for balloon counterpulsation and thrombolysis, often followed by late revascularization. 34,35 …”

Section: Discussionmentioning

confidence: 99%

Early Revascularization in Acute Myocardial Infarction Complicated by Cardiogenic Shock

et al. 1999

View full text Add to dashboard Cite

“…After adjusting for patient variables, including era, access to invasive cardiac care was shown to be independently associated with improved patient in-hospital survival, with an OR of 0.4 (95% CI 0.3 to 0.5). Indeed, several observational studies (18)(19)(20)(21)(22) suggest that access to a catheterization laboratory on-site is associated with survival benefit in patients with CS. Similarly, the SHOCK study reported a significant survival advantage for patients treated with early revascularization compared with patients who did not receive early revascularization at both six months (50% versus 63%; P=0.027) and 12 months (53% versus 66%; P<0.03) (4,23).…”

Section: Discussionmentioning

confidence: 99%

Unequal access to interventional cardiac care in Nova Scotia in patients with acute myocardial infarction complicated by cardiogenic shock

Mayich¹,

Cox

Buth³

et al. 2006

Canadian Journal of Cardiology

View full text Add to dashboard Cite

“…Since then, several observational series have supported the potential benefits of the IABP in patients with AMI treated with thrombolytic therapy and complicated by cardiogenic shock [44][45][46].…”

Section: Cardiogenic Shockmentioning

confidence: 99%

Aortic counterpulsation: A review of the hemodynamic effects and indications for use

Santa-Cruz

Cohen

Ohman

2005

Cathet Cardio Intervent

View full text Add to dashboard Cite

In the ever evolving field of cardiovascular medicine and coronary intervention, the intra-aortic balloon pump (IABP) is a mature technology, which still plays an important role. The balloon pump invasively supports patient hemodynamics by augmenting diastolic perfusion and increasing diastolic blood pressure, thereby increasing coronary perfusion and reducing afterload. Its efficacy has been demonstrated in a multitude of clinical situations, including acute coronary syndromes, high-risk coronary interventions, cardiogenic shock, and cardiovascular surgery. The potential complications of aortic counterpulsation are serious, although much lower than once feared. With proper patient selection, insertion technique, and management, the IABP is a powerful tool to assist in the treatment of patients with cardiovascular disease. This article will review the hemodynamics, indications, and complications associated with its use.

show abstract

Treatment Strategies for Acute Myocardial Infarction Complicated by Cardiogenic Shock in a Community Hospital

Cited by 81 publications

References 16 publications

Early Revascularization in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Early Revascularization in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Unequal access to interventional cardiac care in Nova Scotia in patients with acute myocardial infarction complicated by cardiogenic shock

Aortic counterpulsation: A review of the hemodynamic effects and indications for use

Contact Info

Product

Resources

About